[HTML][HTML] 血管正常化与肿瘤免疫治疗
曾俊莉， 袁冬梅， 刘红兵， 宋勇 - Chinese Journal of Lung Cancer, 2014 - ncbi.nlm.nih.gov
… normalization tumor vascular by anti-angiogenesis properly could improve the
immunosuppressive … Here, we discuss the effects of vascular normalizing on tumor immunity and …
immunosuppressive … Here, we discuss the effects of vascular normalizing on tumor immunity and …
抗血管生成治疗联合免疫检查点抑制剂在实体瘤治疗中的研究进展
刘颖， 李丹阳， 徐淑宁， 乔磊， 李克， 刘莺 - 中国肿瘤临床, 2022 - cjco.cn
… Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive
tumor microenvironment and enhance immunotherapy[J]. Proc Natl Acad Sci USA, 2012, …
tumor microenvironment and enhance immunotherapy[J]. Proc Natl Acad Sci USA, 2012, …
抗血管生成药物对肿瘤免疫调节影响的研究进展
刘清菁， 蒋晓东 - 中国肿瘤临床, 2016 - cjco.cn
… which anti-angiogenesis enhances immunity by influencing tumor microenvironment. …
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor …
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor …
PD-1/PD-L1 抑制剂联合抗血管生成药物治疗晚期三阴性乳腺癌的研究进展
黄世芬， 令晓玲 - 肿瘤防治研究, 2021 - zlfzyj.com
… shown that the treatment with angiogenesis inhibitors can not only normalize blood vessels
and inhibit tumor growth, but … Vascular normalization as an emerging strategy to enhance …
and inhibit tumor growth, but … Vascular normalization as an emerging strategy to enhance …
[HTML][HTML] 肿瘤治疗新方向——免疫检查点抑制剂联合抗血管生成治疗
丰慧， 徐子涵， 聂玉辉， 刘淑真 - Advances in Clinical Medicine, 2021 - hanspub.org
… , but also promote the normalization of tumor blood vessels. … anti angiogenesis therapy is a
mutually beneficial treatment. … 血管内皮细胞生长因子(vascular endothelial growth factor, VEGF…
mutually beneficial treatment. … 血管内皮细胞生长因子(vascular endothelial growth factor, VEGF…
[PDF][PDF] 肿瘤抗血管生成及其与免疫治疗关系的研究进展Research progress in relationship between tumor anti-angiogenesis and immunotherapy
张娜， 刘相良， 徐志强， 马责竣， 徐鹤鸣… - 吉林大学学报(医学版 …, 2021 - xuebao.jlu.edu.cn
… Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive
tumor … mature dendritic cells deteriorated by vascular endothelial growth factor through …
tumor … mature dendritic cells deteriorated by vascular endothelial growth factor through …
[HTML][HTML] 抗血管生成药物联合免疫检查点抑制剂治疗晚期非小细胞肺癌的研究进展
王婧怡， 彭文颖， 江美林， 邬麟 - Chinese Journal of Lung Cancer, 2021 - ncbi.nlm.nih.gov
… tumor therapy. In this review, we focused on the research and application of anti-angiogenic …
性受体为血管内皮生长因子受体2（vascular endothelial growth factor receptor 2, VEGFR-2） [6…
性受体为血管内皮生长因子受体2（vascular endothelial growth factor receptor 2, VEGFR-2） [6…
針對腫瘤微環境之反應來增進單一大劑量放射療法之療效
SY Fu - 清華大學生醫工程與環境科學系學位論文, 2020 - airitilibrary.com
… is consisted of vasculature, infiltrated immune cells, tumor-… tumor, TRAMP-C1, was irradiated
with a large single dose of … , composed accumulated more immunosuppressive type of Ly6G…
with a large single dose of … , composed accumulated more immunosuppressive type of Ly6G…
[PDF][PDF] 免疫检查点抑制剂治疗晚期肝癌的研究进展
李鑫， 高见， 屠红 - 肿瘤, 2021 - tumorsci.org
… Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive
tumor microenvironment and enhance immunotherapy[J]. Proc Natl Acad Sci USA, 2012, …
tumor microenvironment and enhance immunotherapy[J]. Proc Natl Acad Sci USA, 2012, …
局部麻醉藥劑促進腫瘤細胞凋亡之研究
張源清 - 2014 - tdr.lib.ntu.edu.tw
… the physical manipulation of the tumor or its vasculature [37]. … doses increases angiogenesis
and promotes breast tumor … , raw array data were normalized per chip and per gene and …
and promotes breast tumor … , raw array data were normalized per chip and per gene and …